Researchers have developed a statistical algorithm that identifies patients who may best respond to antidepressants — before they begin treatment.
Investigators from McLean Hospital, an affiliate of Harvard Medical School, used data from a recently completed multi-site clinical trial called Establishing Moderators and Biosignatures of Antidepressant Response in Clinical Care (EMBARC).
The paper by Christian A. Webb, Ph.D., and Diego A. Pizzagalli, Ph.D., appears in the journal...
[Read More ...]
No comments:
Post a Comment